Dullart 1992.
Methods | RCT, parallel, 2 arms (n‐6 LA vs SFA), 2 years Summary risk of bias: moderate to high |
|
Participants | Type I diabetics with elevated urinary albumin CVD risk: moderate Control: randomised 20, analysed 20 Intervention: randomised 18, analysed 16 % male: 81% intervention, 75% control Mean (SD) age in years: control 41 (14), intervention 44 (12) Age range: unclear (21‐65 inclusion) Smokers: control 55%, intervention 50% Hypertension: control 10%, intervention 6% Medications taken by at least 50% of those in the control group: insulin Medications taken by 20%‐49% of those in the control group: not reported Medications taken by some, but less than 20% of the control group: anti‐hypertensive drugs Location: Netherlands Ethnicty: not reported |
|
Interventions | Type: dietary advice Comparison: LA (n‐6) vs usual diet Intervention: diet advice given at every visit throughout the 2‐year period to increase linoleic acid achieving a polyunsaturated: saturated fatty acid ratio close to 1.0. Advice to replace butter or saturated margarines by polyunsaturated margarines and to restrict the intake of saturated fat from meat and milk products Control: to continue their usual diet. All participants were urged not to alter total fat and protein content. Dose: (intake data) intervention group 13% E SFA, P/S 0.985, PUFA 9.4% E. Control group 15% E SFA, P/S 0.45, PUFA 6.6% E (CHO and protein were consistent between groups across the trial). Increase 2.8% E PUFA, most of which n‐6 Baseline n‐6: unclear, 6.6% E PUFA, most of which was n‐6 Compliance: poor, no significant difference between plasma cholesteryl ester LA in intervention and control at 2 years Plasma cholesteryl esters at 2 years
Dietary assessment using 1 week dietary recall, reported at 2 years
Duration of intervention: 2 years |
|
Outcomes | Main study outcomes: albuminurea and lipids Dropouts: intervention 2 of 20, control 4 of 20 Available outcomes: weight, HDL cholesterol, TGs, HbA1c (total cholesterol, LDL, glucose, insulin reported but too different at baseline to use, renal outcomes such as GFR, albuminurea, mean arterial pressure not used) |
|
Notes | Most outcomes are estimated from figures Study funding: Dutch Diabetes Research Fund Response to contact: yes, Prof Dullart confirmed that no CVD events or deaths occurred |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote: "patients were stratified according to sex and randomised in blocks of ten men and six women" |
Allocation concealment (selection bias) | Low risk | Assigned using opaque sealed envelopes by independent statistical investigator with no contact with participants |
Blinding of participants and personnel (performance bias) All outcomes | High risk | No information on blinding. Participants could not be blinded as they received dietary advice |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No details |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | No details on dropouts apart from the exclusion of 2 intervention participants from the trial due to pregnancy and decision not to participate |
Selective reporting (reporting bias) | Unclear risk | No protocol or trial registration located |
Attention Bias | High risk | Intervention groups received diet advice at every visit. As the control group were advised to stick to their usual diet it is likely that they received less attention and time. |
Compliance | High risk | Compliance poor assessed by biomarkers |
Other bias | Low risk | None noted |